To corroborate these results in a human-human model, we co-cultured H1975 cells with donor-derived human PBMCs and combined osimertinib with the humanised IgG1 anti-HER3, EV20 [25], where the combination treatment significantly increased tumor cell elimination (Fig. 3C). Here, ERBB3 is linked to neoplasm.